Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.28 USD | +0.68% | -0.12% | +9.26% |
Financials (USD)
Sales 2024 * | 4.49B | Sales 2025 * | 4.65B | Capitalization | 7.97B |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | 82M | EV / Sales 2024 * | 2.86 x |
Net Debt 2024 * | 4.87B | Net Debt 2025 * | 4.38B | EV / Sales 2025 * | 2.65 x |
P/E ratio 2024 * |
-263
x | P/E ratio 2025 * |
65.1
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.35% |
Latest transcript on Elanco Animal Health Incorporated
1 day | +0.68% | ||
1 week | +0.62% | ||
Current month | +2.45% | ||
1 month | -1.09% | ||
3 months | +10.00% | ||
6 months | +46.40% | ||
Current year | +9.26% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 62 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 68 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 227 M€ | +6.28% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 18 M€ | +7.01% | - | |
0.33% | 2 M€ | +12.97% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 16.28 | +0.68% | 2,321,926 |
24-03-27 | 16.17 | +1.76% | 2,022,403 |
24-03-26 | 15.89 | -0.13% | 2,792,961 |
24-03-25 | 15.91 | +0.57% | 1,899,513 |
24-03-22 | 15.82 | -2.94% | 2,516,541 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.26% | 7.97B | |
-14.27% | 77.16B | |
+4.62% | 3.09B | |
-3.76% | 3.07B | |
-21.25% | 1.31B | |
+9.80% | 1.29B | |
-20.24% | 1.29B | |
-2.83% | 1.28B | |
-14.08% | 1.11B | |
+4.89% | 971M |